Jonathan L Vennerstrom

USPTO Granted Patents = 18 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 134(Granted Patents)

Company Filing History:

12 out of 730

University of Nebraska

Medicines for Malaria Venture (mmv)

patents

4. 2 out of 3,685

Johns Hopkins University

patents

5. 1 out of 1

Medicines for Malaria Venture Mmv International Centre Cointrin

patent

where one patent can have more than one assignee

Years Active: 1996-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11963945 - Ozonides for treating or preventing virus infections (2024-04-23),

2. 11246854 - Ozonides for treating or preventing virus infections (2022-02-15),

3. 10881630 - Creatine oral supplementation using creatine hydrochloride salt (2021-01-05),

4. 10531680 - Creatine ester pronutrient compounds and formulations (2020-01-14),

5. 10342771 - Creatine oral supplementation using creatine hydrochloride salt (2019-07-09),

6. 9962352 - Creatine oral supplementation using creatine hydrochloride salt (2018-05-08),

7. 9486424 - Creatine oral supplementation using creatine hydrochloride salt (2016-11-08),

8. 8962685 - Creatine oral supplementation using creatine hydrochloride salt (2015-02-24),

9. 8354450 - Creatine oral supplementation using creatine hydrochloride salt (2013-01-15),

10. 8067620 - Dispiro 1,2,4-trioxolane antimalarials (2011-11-29),

11. 8026385 - Creatine oral supplementation using creatine hydrochloride salt (2011-09-27),

12. 7608641 - Creatine oral supplementation using creatine hydrochloride salt (2009-10-27),

13. 7371778 - Spiro and dispiro 1,2,4-trioxolane antimalarials (2008-05-13),

14. 6906205 - Spiro and dispiro 1,2,4-trioxolane antimalarials (2005-06-14),

15. 6897334 - Production of creatine esters using in situ acid production (2005-05-24),

Title: The Innovative Journey of Jonathan L. Vennerstrom

Introduction: Jonathan L. Vennerstrom, based in Omaha, NE, is a prolific inventor with a remarkable portfolio of 18 patents to his name. His inventive contributions primarily focus on methods for treating or preventing viral infections, showcasing his commitment to advancing medical science and public health.

Latest Patents: Among his most recent innovations are two pivotal patents related to ozonides. These patents describe methods for treating or preventing viral infections in subjects through the administration of ozonides. This groundbreaking approach holds promise in improving therapeutic options for various viral diseases.

Career Highlights: Jonathan has had a significant impact in the field of research and innovation during his career. He has notably worked with the University of Nebraska, where he has contributed to academic advancements and research initiatives. Additionally, his role at Vireo Systems, Inc. has further enabled him to translate his innovative ideas into practical applications that can benefit society.

Collaborations: Throughout his journey, Jonathan has collaborated with esteemed professionals such as Donald W. Miller and Mark C. Faulkner. These partnerships have enriched his research endeavors and expanded the reach of his innovative work in the scientific community.

Conclusion: Jonathan L. Vennerstrom stands out as a notable figure in the realm of invention and innovation. His dedication to developing solutions for viral infections through his ozonide patents underscores the importance of inventive minds in combating health challenges. With a solid foundation in academic and practical applications, Jonathan continues to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.